The Trump administration has capped indirect costs for National Institutes of Health research grants at 15%. That would wipe ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback